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Abstract
SRY is a sex-determining gene that encodes a transcription factor, which triggers male development in most mammals. The
molecular mechanism of SRY action in testis determination is, however, poorly understood. In this study, we demonstrate
that WDR5, which encodes a WD-40 repeat protein, is a direct target of SRY. EMSA experiments and ChIP assays showed that
SRY could bind to the WDR5 gene promoter directly. Overexpression of SRY in LNCaP cells significantly increased WDR5
expression concurrent with histone H3K4 methylation on the WDR5 promoter. To specifically address whether SRY
contributes to WDR5 regulation, we introduced a 4-hydroxy-tamoxifen-inducible SRY allele into LNCaP cells. Conditional SRY
expression triggered enrichment of SRY on the WDR5 promoter resulting in induction of WDR5 transcription. We found that
WDR5 was self regulating through a positive feedback loop. WDR5 and SRY interacted and were colocalized in cells. In
addition, the interaction of WDR5 with SRY resulted in activation of Sox9 while repressing the expression of b-catenin. These
results suggest that, in conjunction with SRY, WDR5 plays an important role in sex determination.
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Introduction
WDR5, also named BIG-3, was first identified in a murine
prechondroblastic cell line by differential display PCR following
induction with BMP-2. Analysis of liver, spleen, kidney, and other
tissues showed that the highest level of WDR5 expression was in
testis [1]. WDR5 is a member of the WD-40 repeat protein
family, which exhibits a seven-bladed propeller-like structure with
a narrow channel running through the center [2,3].
In the last several years,studies have focused on the role of
WDR5 associated with MLL and SET1 complexes, which trigger
methylation of histone H3K4. WDR5 is the core component of
the MLL/SET1 complex, and it is indispensable for assembly and
effective methyltransferase activity of the complex [2]. It was
shown that WDR5 interacts with histone H3 regardless of the
methylation status of the Lysine 4 residue [2]. WDR5 regulates
osteoblast differentiation and vertebrate development [4,5]. In
addition, WDR5 has been shown to be a regulator of embryonic
stem cell self-renewal, and its expression correlates with the
undifferentiated state [6]. However, it is not known how WDR5
itself is regulated.
SRY is a testis-determining gene located on the Y-chromo-
some, which triggers male development in most mammalian
embryos. Mutations in SRY are associated with human XY
gonadal dysgenesis [7]. The open reading frame (ORF) of human
SRY contains only a single exon and encodes a 204-amino-acid
protein, which is composed of three regions: a central 79 amino
acids HMG domain, C-terminal domain, and N-terminal
domain. The HMG domain, which is highly conserved between
species, binds sites in the minor groove of DNA and introduces
local conformational changes that influence transcription of genes
downstream [8–10]. SRY, a member of the Sox (SRY-related
HMG box) gene family, interacts with CaM (calmodulin) and
importin b and facilitates translocation of proteins from
cytoplasm to nucleus [11,12]. Unlike mouse, human SRY lacks
a C terminal transcription activation domain necessary for male
sex determination, suggesting that human SRY may function
through interaction with additional transcriptional co-activators.
In vitro analysis of recombinant SRY protein suggests that it
recognizes a degenerate motif (A/T)AACAA(A/T), making it
difficult to identify its in vivo targets [13]. To date, few regulatory
target genes of SRY have been identified; these include Sox9,
Cbln4, TCF21, and NTF3 [14–17]. The molecular mechanism
of SRY action in testis determination is poorly understood
[18,19].
In this study, we show that WDR5 is a direct target of SRY.
The interaction of WDR5 and SRY activates Sox9 expression. As
Sox9 is the master regulator of sex determination [18,19], we
hypothesize that WDR5 interacts with SRY to promote testis
development.
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Identification of potential SRY binding sites in the
proximal WDR5 promoter
The human WDR5 gene has two transcript variants, which
encode the same protein but differ in the 59UTR (Fig. S1A).
Alignment of the proximal promoter of the WDR5 gene (between
22000 bp and +1 bp) in different vertebrates reveals that the
proximal promoter of Variant 2 (the shorter variant) is more
conserved (Fig. S1B). Thus, in this study, we focused on the
Variant 2 promoter to investigate transcriptional regulatory
mechanisms of WDR5.
To predict potential transcription factors, we used the TF-
SEARCH program (http://www.cbrc.jp/research/db/
TFSEARCH.html) to search a 2.0-kb fragment of genomic
DNA that contains part of the first exon of WDR5 and 59UTR.
The result revealed that within the proximal 200 bp promoter
region several transcription factors were likely to bind, including
CdxA, GATA-1, and SRY (Fig. 1A). Notably, there were two
predicted SRY binding sites in this region (sequence: TTTGTTT),
which were exactly complementary to the SRY binding consensus
sequence (A/T)AACAA(A/T). These sites were further checked
using ConSite (http://mordor.cgb.ki.se/cgibin/CONSITE/
consite/) software (Fig. 1B). Alignment of the region (2101 bp
to +1 bp) between human, rhesus, and mouse showed that the
binding site of SRY at –11 bp was more conserved than the site at
294bp. We hypothesized that these two sites might be SRY
binding sites.
To isolate the 59-flanking region of the WDR5 gene containing
the two SRY binding sites, a 249-bp fragment of genomic DNA
(2134 to +115 of the WDR5 gene) was amplified and subcloned
into a pGL3-basic vector. In order to test whether SRY could
function on this reporter construct, the reporter construct was
cotransfected with either an SRY expression plasmid (pCXN-2-
SRY-3HA) or an empty plasmid (pCXN-2) into human prostate
adenocarcinoma LNCaP cells, which have very low expression
levels of endogenous SRY, and relative luciferase activity was
analyzed. Compared to empty vector, luciferase activity was
increased 3.6-fold when cells were transfected with SRY
expression plasmid (Fig. 1C). To verify that the SRY binding
elements functioned for activation of human WDR5 expression,
we constructed three reporter plasmids in which point-mutations
were introduced into one or both SRY binding sites, and tested
luciferase activity. Luciferase activity from mutants in which either
SRY binding element was mutated was significantly reduced
compare to the wild type. Moreover, luciferase activity from a
mutant in which both SRY binding sites were mutated was further
reduced (Fig. 1D). These data indicated that these two SRY
binding sites contributed to the transcriptional activity of human
WDR5.
SRY binds to the promoter of WDR5
To determine if SRY bound the WDR5 promoter directly,
electrophoretic mobility shift assays were performed. A wild type
labeled probe bound the nuclear extract from transfected LNCaP
cells overexpressing HA-tagged SRY (Fig. 2A, lane 2). This
binding was ablated by competition with unlabeled wild type
probe, but not by competing mutant probe (Fig. 2A, lanes 3, 4). A
supershift band was observed when anti-HA antibody was added
in nuclear extract incubated with wild type labeled probe, but not
with control IgG (Fig. 2A, lanes 5, 6). This experiment indicated
that SRY bound the WDR5 promoter in vitro.
Because of a lack of a high quality ChIP-grade antibody against
human SRY, we performed ChIP assays on LNCaP cells
overexpressing HA-tagged SRY, as above, to confirm that SRY
associated with the endogenous WDR5 promoter. The results
demonstrated that precipitation of HA-SRY brought down the
WDR5 promoter, but did not bring down a control region
upstream of the WDR5 promoter, or a negative control promoter,
MyoD (Fig. 2B). Taken together, results of both EMSA and ChIP
assays indicated that SRY binds WDR5 promoter.
SRY activates WDR5 expression
In order to assess the effect of SRY on endogenous protein, both
WDR5 mRNA and protein expression levels were analyzed in
LNCaP cells stably overexpressing HA tagged SRY. Consistent
with reporter gene assays, overexpression of SRY induced
endogenous WDR5 expression as shown in Western blot assay
with anti-WDR5 antibodies (Fig. 3A). To confirm this result, we
performed real-time PCR using specific primer for WDR5 cDNA.
We found that the WDR5 mRNA level was three-fold higher in
SRY overexpressing cells than control (Fig. 3B). In order to
examine changes in epigenetic histone modification marks, we
performed ChIP analyses of the WDR5 gene promoter with
antibodies to H3K4me2, H3K4me3, and H3K27me3. Consistent
with the expression data, histone H3K4me2 and H3K4me3 on the
WDR5 promoter were enriched whereas H3K27me3 remained
unchanged. We observed that WDR5 binding to its own promoter
was significantly increased as well (Fig. 3C).
To further confirm that SRY activates WDR5 expression
specifically, we established an inducible system using 4-OHT
induction, and performed a time course assay. The ERtm domain
(amino acids 281–599 of murine estrogen receptor with a Glycine
to Arginine substitution at amino acid 525) was fused to the full
length HA tagged SRY, separated by a glycine-rich linker
(Fig. 3D). The modified ERtm domain is deficient in binding
endogenous estrogen, but remains responsive to activation by the
synthetic estrogen derivative 4-OHT or its precursor tamoxifen.
Proteins fused to ERtm are retained outside the nucleus in a
complex with heat shock proteins (Hsp), such as Hsp90. Upon
binding to 4-OHT, the fusion protein is released and shuttled into
the nucleus where it acts as a transcription factor [20]. The
assembled cDNA was inserted into a murine stem cell virus
(MSCV)-based retroviral vector MSCV-IRES-GFP, yielding
MSCV-SRY-HA-ERtm-IRES-GFP. Using FACS sorting, we
generated a stable LNCaP cell line overexpressing SRY-HA-
ERtm. Expression of SRY-HA-ERtm was determined by
immunoblotting with a monoclonal antibody against HA
(Fig. 3D). LNCaP cells stably overexpressing SRY were harvested
at different times after 4-OHT treatment. RNA from these cells
was isolated and analyzed by quantitative real time PCR, which
revealed that WDR5 mRNA levels were significantly increased
after 24 hours induction (Fig. 3E). Consistent with this, anti-HA
antibody ChIP experiments indicated that HA-tagged SRY was
increasingly enriched on the WDR5 promoter following 4-OHT
treatment (Fig. 3F). This result suggested that the accumulated
SRY on the WDR5 promoter could be directly activating WDR5
expression.
WDR5 regulates itself through a feedback loop
Since WDR5 binds its own promoter (Fig. 3C), we investigated
whether WDR5 regulated its own expression. To test this, we
generated a stable LNCaP cell line which overexpressed WDR5
protein exogenously. Endogenous mRNA can be distinguished
from total mRNA by real time-RT-PCR using two different pairs
of primers (Fig. 4A). Q-RT-PCR analysis revealed that the
endogenous WDR5 mRNA level was increased 2-fold compare to
the control, while the total WDR5 mRNA level was increased
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indicated that WDR5 could activate itself through positive
feedback.
SRY cooperates with WDR5 to induce Sox9 expression
and repress b-catenin expression
Next, we examined whether WDR5 could interact with SRY in
vivo. To test this, we performed immunofluorescent staining
experiments. The results showed that WDR5 co-localized with
Figure 1. Identification of potential SRY binding sites in WDR5 proximal promoter. (A) Schematic representation of WDR5 proximal
promoter with two potential SRY binding sites and GATA1 and CdxA binding sites. (B) Alignment of WDR5 proximal promoters between human,
rhesus, and mouse. Regions in frame represent the SRY binding sites. (C) Relative luciferase activity assay from cells containing either vector or
overexpressing SRY. Graphs show mean 6 SD, n=3 (left panel). Western blot analysis of HA-tagged SRY and loading control, Hsp70 (right panel). (D)
Relative luciferase activity assay from cells containing either wild type promoter or mutant promoters with either vector or HA tagged SRY. Graphs
show mean 6 SD, n=3. *P,0.05, **P,0.01 compared to wild type (top panel); Student’s t-test.
doi:10.1371/journal.pone.0034327.g001
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reChIP (anti-HA followed by anti-WDR5) experiment demon-
strated that SRY and WDR5 interacted on the Sox9 promoter,
but not a control region upstream of the promoter (Fig. 5B). The
interaction between WDR5 and SRY was verified by co-
immunoprecipitation experiments in which cellular extracts from
LNCaP cells overexpressing SRY-3HA were co-immunoprecipi-
tated with anti-HA antibody and blotted with anti-WDR5
antibody (Fig. 5C). SRY was expected to recruit more MLL
complex components rather than to disrupt the complex (Fig. S2).
SRY is the critical gene that initiates male sex determination in
most mammals. The best direct target for SRY is Sox9. In order to
determine whether SRY or WDR5 can regulate Sox9 expression,
we established LNCaP cell lines which expressed either SRY,
WDR5, or both together with the nuclear orphan receptor,
steroidogenic factor (SF1). Real time PCR results indicated that
SRY and WDR5 together activated the expression of Sox9
significantly more than either alone (Fig. 5D). Consistent with their
function in triggering male sex determination, SRY and WDR5
significantly reduced the expression levels of b-catenin, which is
important for development of ovaries (Fig. 5E). Expression of
WDR5, HA tagged SRY, and HA tagged SF1 was confirmed by
Western blot (Fig. 5F). To further probe the direct role of WDR5
alone on Sox9 expression, we generated two WDR5 knockdown
(WDR5i-1 and WDR5i-2) LNCaP cell lines using specific short
hairpin RNAs, and a scrambled control line. In the knockdown
lines, WDR5 levels were reduced to about 20% of the scrambled
cells (Fig. 5G, 5H), and Q-RT-PCR demonstrated a 20-45%
decrease in Sox9 expression in these cells compared to control cells
(Fig. 5I). In aggregate, these results suggest that WDR5 together
with SRY could play an important role in sex determination.
Localization of the WDR5 protein and expression of the
WDR5 gene in the murine embryonic testis
To study the expression pattern of WDR5 in mouse embryonic
testis, timed-pregnant mice were set up. Genital ridges from
different days of these mice were collected and sectioned for
immunofluorescent analysis with specific antibodies. At 11.5 dpc
(days post-coitum), WDR5 was localized to germ cells and co-
localized with Sox9 in somatic cells (Fig. 6A). At 12.5 dpc, WDR5
immunopositive cells were found predominantly in germ cells and
occasionally in Sertoli cells (Fig. 6B). At 13.5 dpc, WDR5 was
detected in germ cells, Sertoli cells, and in the interstitium
(Fig. 6C). Of note, WDR5 was mostly localized in the cytoplasm
rather than in the nucleus. It has previously been reported that
WDR5 is more abundant in the cytoplasm than in the nucleus of
human embryonic kidney 293 cells, and that it can be translocated
from the nucleus to the cytoplasm during viral infection [21].
However, the movement of WDR5 between nucleus and
cytoplasm in developing testes is currently unknown. The
differential localization of WDR5 at different stages of develop-
ment suggested different roles and functions for WDR5 in testis
differentiation and sex determination. In order to confirm whether
SRY binds the WDR5 promoter in vivo, ChIP analysis was
performed from E13 rat gonads. The results demonstrated
significant enrichment of SRY on the WDR5 promoter, similar
to SRY binding on the Tcf21 promoter, a positive control
(Fig. 6D). Moreover, Q-RT-PCR revealed that WDR5 and Sox9
displayed a similar expression profile in rat gonads from E13 to
E15 (Fig. 6E). In aggregate, these results indicted that WDR5 and
SRY are likely to have direct regulatory effects on Sox9
expression.
Discussion
Although WDR5 is a core subunit of MLL/SET1 complexes, it
also functions as a subunit of other complexes. WDR5 has been
shown to be important in bone morphogenesis, vertebrate
development, and embryonic stem cell renewal [4–6]. However,
a function of WDR5 in sex determination has not been previously
reported. In this study, we demonstrated that WDR5 is a direct
target of SRY. In addition, WDR5 can regulate itself through a
positive feedback loop. Furthermore, WDR5 can synergize with
SRY to activate Sox9 while repressing the expression of b-catenin.
All these results suggest that WDR5 may have an important role in
sex determination.
Since the SRY gene was discovered in 1990, an answer to the
question as to how SRY promotes testis differentiation has
remained elusive [7,22,23]. Although some pathways regulating
sexual differentiation have been elucidated, the details of SRY
function were poorly understood. Currently, the dominant theory
is that SRY plays a critical role in early gonad development in
either direction (male or female) by pushing the balance to favor
the male development pathway [18,19]. In this process, Sox9,
which is regulated by SRY, controls Sertoli cell formation and,
consequently, testis differentiation. In our experiment, we showed
Figure 2. SRY binds to WDR5 promoter. (A) EMSA analysis of HA
tagged SRY with wild type and mutant probes. Arrows indicate SRY-
probe complex and supershift. (B) ChIP analysis of HA tagged SRY on
WDR5 promoter,WDR5 promoter proximal upstream region, or MyoD
promoter. Mouse IgG serves as a negative control. Graphs show mean
6 SD, n=3.
doi:10.1371/journal.pone.0034327.g002
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WDR5 subsequently acts together with SRY to promote Sox9
expression.
The auto feedback loop involved in the regulation of WDR5 is
interesting. During testis differentiation, many feedback loops have
been observed. In mouse, SRY is expressed for only a short
developmental period (dpc10.5–12.5) [24,25], but Sox9 expression
needs to be maintained for testis formation. Sox9 has been shown
to contribute to its own expression [14]. In addition, a target gene
of Sox9, Fgf9, also displays a positive feedback loop in which its
expression helps to activate Sox9 [26]. In contrast to Fgf9, WDR5
seems to act upstream of Sox9. This may be a common scenario of
how sex differentiation is achieved.
Most studies of mammalian sexual determination have been
carried out using mouse models. In mice, at dpc10, genital ridges
are formed without morphological differences between male and
female [18]. At this time in male differentiation, SRY begins to be
expressed and triggers expression of other genes involved in the
differentiation of Sertoli cells. Female-specific gene expression
leading to differentiation of granulose cells must be repressed [19].
b-catenin, a signature gene in ovary development, needs to be
repressed [27]. This is consistent with our results that SRY and
WDR5 together not only increase Sox9 expression, but also
repress b-catenin expression.
The question arises, how can SRY and WDR5 play opposite
roles on different genes? There is little doubt that different
transcription factors or epigenetic modifiers and co-factors
recruited by SRY and WDR5 must help to determine gene
activity. In fact, histone H3K4 methylation, which is usually
associated with WDR5, has been shown to be a dual factor.
Although H3K4 methylation is largely associated with transcrip-
tion initiation and elongation [2,28], some evidence indicated that
this mark could also be involved in gene repression. In yeast,
H3K4me2/3 induced by Set1 can directly contribute to repressive
machinery on PHO5 and PHO84 genes [29,30]. H3K4me3 can
also be recognized by ING2, a component of the Sin3-HDAC
complex, to repress the Cyclin D gene in mammalian cells [31].
However, we could not exclude the possibilities that WDR5 and
SRY recruit different co-factors to act on different genes.
Figure 3. SRY activates WDR5 expression. (A) Western blot analysis of HA tagged SRY, Hsp70, and WDR5 from LNCaP cells containing either
control vector (Ctrl) or HA-tagged SRY. Relative quantitation of WDR5 protein with ImageJ software (NIH, USA) is shown on the bottom. (B)
Quantitative real-time analysis of WDR5 levels as in (A). Graphs show mean 6 SD, n=3. (C) ChIP analysis on WDR5 promoter with indicated antibodies
as in (A). Graphs show mean 6 SD, n=3. (D) Schematic representation of HA-SRY-ERtm construct. Numbers show the respective amino acid positions
of the individual constituents (upper panel). Western blot analysis of SRY-HA-ERtm expression with anti-HA antibody. A triangle indicates non-specific
bands (lower panel). (E) Quantitative real time analysis of WDR5 levels from cells with SRY-3HA-ERtm after induction by 4-OHT at indicated time
points. Graphs show mean 6 SD, n=3. (F) ChIP analysis on WDR5 promoter with either IgG or anti-HA antibody as in (E). Graphs show mean 6 SD,
n=3. *P,0.05, **P,0.01, #P.0.05 compared to control; Student’s t-test.
doi:10.1371/journal.pone.0034327.g003
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of SRY. More interestingly, WDR5 can further cooperate with
SRY to regulate Sox9 and b-catenin expression. It would be
interesting to determine the molecular mechanism by which SRY
plays a dual role at the early stage of mammalian sex
determination. The finding that WDR5 cooperates with SRY will
help probe their roles in testis differentiation.
Materials and Methods
Antibodies and reagents
Anti-HA (12CA5) antibody was purchased from Roche. Anti-
WDR5, anti-H3K4me2, and anti-H3K27me3 antibodies were
purchased from Abcam. Anti-H3K4me3 antibody was purchased
from Millipore. Anti-Hsp70 and anti-SRY (mouse) antibodies
were purchased from Santa Cruz. The pGL3-Basic luciferase
vector was purchased from Promega. DMEM, RPMI 1640, and
fetal bovine serum were obtained from Life Technologies.
Cell lines
LNCaP cells (gifted by Dr. Jiemin Wong, East China Normal
University, China) were seeded in a 100-mm dish and transfected
with 10 mg pCXN-2-SRY-3HA plasmid when the confluency
reached 80%; 36 hours after transfection, cells were supplied with
fresh media containing 600 mg/ml G418. Resistant clones were
selected within 15–20 days and expanded. The G418 concentra-
tion was maintained at 400 mg/ml in the cell culture medium.
The WDR5 coding regions and SRY-3HA-ERtm sequence
were cloned into the retroviral vector plasmid 3HA-MSCV-IRES-
GFP at unique XhoI or EcoRI sites and amphotropic viral
supernatant was obtained as described previously [32].
The siRNA target sequences for WDR5 were inserted into the
XhoI/HpaI sites in the pLL3.7 lentiviral vector according to the
manufacturer’s recommendations (American Type Culture Col-
lection, USA). The oligonucleotides are:
WDR5i-1 sequences: GTGGAAGAGTGACTGCTAA;
WDR5i-2 sequences: GAATGAGAAATACTGCATA
Retroviral supernatant was filtered and added to LNCaP cells
every 24 hours for 3 days. Lentivirus production in 293T cells and
infection of LNCaP cells were performed as described previously
[33]. Cells expressing GFP were sorted by sterile flow cytometry
and expanded.
Site-directed mutagenesis and luciferase reporter assay
Genomic DNA was extracted from 293T cells as described
previously [34]. A fragment (2134 to +115) containing the
proximal promoter of WDR5 was amplified by PCR using the
following primers: sense, 59-GCGGTACCAGGACTTAGGG-
GAATTAATAG -39, which contained a KpnI restriction site
and antisense, 59-CGCAGATCTGTCTCGGGCTTCTTCTC-
39, which contained a BglII restriction site. The PCR product was
cloned into the pGL-3 vector. Mutations were obtained using a
site-directed mutagenesis kit (SBS technologies, Shanghai). All
mutated insert fragments were confirmed by sequencing.
For the luciferase reporter assay, 3610
4 LNCaP cells were
plated in 12 well plates 24 hours prior to transfection. Triplicate
wells were transiently transfected with the indicated plasmids using
lipofectamine 2000 (Life technologies), and 36 hours after
transfection, relative luciferase activity was measured using the
Luciferase Reporter Assay System (Promega). Beta-galactosidase
assays were performed as normalization controls according to the
Cold Spring Harbor Protocol [35]. b-galactosidase enzyme
activity was measured using a Universal Microplate Spectropho-
tometer.
Co-immunoprecipitation, immunofluorescence, and
histology
For co-immunoprecipitation studies, nuclear extracts were
extracted from LNCaP cells and incubated with HA or WDR5
antibodies for 2 hours at 4uC. A 50% slurry of protein G
Sepharose was added and incubated overnight at 4uC. The
mixture was then centrifuged and the pellet was washed 4 times in
50 mM Tris-HCl, pH 7.9, containing 150 mM NaCl prior to
being resuspended in SDS loading buffer. Samples were separated
by SDS-PAGE, immunoblotted, and probed with the relevant
antibodies. Western blots were detected by using an ECL kit
according to the instructions of the manufacturer (Thermo
Scientific).
For immunofluorescence, LNCaP cells overexpressing SRY-
3HA were mounted on polylysine slides and fixed in 4%
paraformaldehyde for 30 min. After being permeabilized with
0.1% (v/v) Triton X-100, cells were blocked in PBS containing
10% goat serum for 30 min at room temperature. The cells were
then incubated with the polyclonal anti-rabbit WDR5 and anti-
mouse HA primary antibodies at 4uC overnight. After washing
cells four times with PBS, secondary antibodies, goat TexasRed
anti-rabbit IgG and FITC anti-mouse IgG (Vector Laboratories)
were applied in PBS for 1 h at room temperature. The slides were
washed and counterstained with 4,6-diamidino-2-phenylindole
(DAPI) for 3 min before imaging with a Nikon Eclipse 80i
microscope (Nikon).
For mouse histology and immunofluorescence analysis, genital
ridges from timed-pregnant mice were collected at E11.5, E12.5,
and E13.5. Sex was determined for Sry on genomic DNA from
embryo tails by standard PCR. Animal studies were approved by
the Animal Care and Use Committee of the Model Animal
Research Center, the host for the National Resource Center for
Figure 4. WDR5 regulates itself through positive feedback
loop. (A) Schematic representation of primers to detect total (F1 and
R1) and endogenous (F2 and R2) WDR5 mRNA. (B) Total WDR5 mRNA
levels from cells containing either control vector (Ctrl) or overexpressing
WDR5. Graphs show mean6SD, n=3. (C) Endogenous WDR5 mRNA
levels as in (B). Graphs show mean 6 SD, n=3. *P,0.05 compared to
control; Student’s t-test.
doi:10.1371/journal.pone.0034327.g004
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fixed in 4% paraformaldehyde and dehydrated through 30%
sucrose solution two hours later. Fixed tissues were embedded in
Jung Tissue Freezing Medium, and serially sectioned. Sections
were washed three times in PBS,transferred to blocking solution
containing 5% donkey serum in 0.1% Tween/PBS for 1 hour,
and incubated with primary antibody at 4uC overnight. After
washing with PBS, the secondary antibody was added and sections
were incubated for 2 hours at room temperature. Slides were
mounted and analyzed with a BX51 Olympus fluorescence
microscope connected to a DP 20 digital camera (Olympus
Corporation, Japan). Combinations of the first and secondary
antibody were as follows: rabbit anti-Sox9 (1:50; Santa Cruz, sc-
20095) and goat anti-WDR5 (1:50; R&D, AF5810); FITC donkey
Figure 5. SRY cooperates with WDR5 to induce Sox9 expression. (A) Immunofluorescence analysis of HA-tagged SRY and WDR5 in LNCaP
cells. (B) ChIP-reChIP (anti-HA antibody ChIP followed by anti-WDR5 antibody ChIP) analysis of HA-tagged SRY and WDR5 on Sox9 promoter, or Sox9
promoter proximal upstream region. Graphs show mean 6 SD, n=3. (C) Coimmunoprecipitation of WDR5 and HA-tagged SRY from LNCaP cells. (D)
Quantitative real time PCR analysis of Sox9 levels from LNCaP cells containing SF1, SF1+WDR5, SF1+SRY, or SF1+SRY+WDR5. Graphs show mean 6
SD, n=3. *P,0.05, **P,0.01 compared to SF1 control; Student’s t-test. (E) Quantitative real time PCR analysis of b-catenin levels as in (D). Graphs
show mean 6 SD, n=3. *P,0.05, **P,0.01 compared to SF1 control; Student’s t-test. (F) Western blot analysis of cellular lysate from cells as in (D).
(G) Western blot analyses of cellular extracts from WDR5i-1 and WDR5i-2 or scrambled control (Ctrl) LNCaP cells with indicated antibodies. (H) WDR5
gene expression analysis by Q-RT-PCR of RNA from WDR5i-1, WDR5i-2 and scrambled control (Ctrl) LNCaP cells. Graphs show mean 6 SD, n=3.
*P,0.05 compared to the scrambled control, Student’s t-test. (I) Sox9 gene expression analysis by Q-RT-PCR of RNA from WDR5i-1, WDR5i-2 and
scrambled control (Ctrl) LNCaP cells. Graphs show mean6SD, n=3. **P,0.01 compared to the scrambled control, Student’s t-test.
doi:10.1371/journal.pone.0034327.g005
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donkey anti-rabbit IgG (1:200; Invitrogen, A21207).
RNA isolation and Real time-PCR
RNA was isolated from cells with Trizol reagent (Life
Technologies) according to the manufacturer’s protocol. cDNA
was synthesized with the SuperScript first-strand synthesis system
(Life Technologies). Q-RT-PCR primers are provided as follow-
ing. Real-time quantitative RT-PCR was performed using the
FastStart Universal SYBR Green Master (Roche) in a Rotorgene
6000 (Corbett Research) in a final volume of 20 ml. Cycling
conditions were 94uC for 15 s, 60uC for 30 s and 72uC for 30 s.
Each reaction was done in triplicate.
The primers for human hypoxanthine guanine phosphoribosyl-
transferase (HPRT) were:
forward 59-ATGGACAGGACTGAACGTCT,
reverse 59-CTTGCGACCTTGACCATCTT.
The primers for human WDR5 were:
forward 59-CACAAGCTGGGAATATCCGATG,
reverse 59-GGGGATTGAAGTTGCAGCAAAA.
The primers for human WDR5 (UTR) were:
forward 59-CGAGAGACTGTCGGGAAGTTG,
Figure 6. Immunolocalization of WDR5 protein and gene expression in embryonic testis. (A) Immunofluorescent staining of WDR5 (in
green) and Sox9 (in red) protein in mouse E11.5 testis. Soc, Somatic cells; GC, Germ cells. Scale bar, 20 mM. (B) Immunofluorescent staining of WDR5
(in green) and Sox9 (in red) protein in mouse E12.5 testis. SC, Sertoli cells; GC, Germ cells. Scale bar, 20 mM. (C) Immunofluorescent staining of WDR5
(in green) and Sox9 (in red) protein in mouse E13.5 testis. IC, interstitial cells. Scale bar, 20 mM. Data shown are representative of three independent
experiments. (D) ChIP analysis of SRY on rat WDR5 promoter and Tcf21 promoter. Graphs show mean 6SD, n=3. **P,0.01 compared to control;
Student’s t-test. (E) Quantitative real time PCR analysis of WDR5, Sox9, and SRY levels relative to b-actin in male rat gonads at indicated embryonic
stages.
doi:10.1371/journal.pone.0034327.g006
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The primers for human Sox9 were:
forward 59-TACGACTGGACGCTGGTG,
reverse 59-TCTCCAGAGCTTGCCCAGCGT.
The primers for human b-catenin were:
forward 59-GAAACGGCTTTCAGTTGAGC,
reverse 59-CTGGCCATATCCACCAGAGT
The primers for rat WDR5 were:
forward 59-CGTGAGTTCCGGAAAGTGTCTGAAG,
reverse 59-GAAATGAACGGCTGAGACTGGAT
The primers for rat Sox9 were:
forward 59-TGAAGATGACCGACGAGCAGGAGAAG,
reverse 59-CTTCCTCGCTCTCCTTCTTCAG
The primers for rat SRY were:
forward 59-CATCGAAGGGTTAAAGTGCCA,
reverse 59-ATAGTGTGTAGGTTGTTGTCC
The primers for rat b-Actin were:
forward 59-GTCGACAACGGCTCCGGCA,
reverse 59-AGGTCTCAAACATGATCTGGGT
Electrophoretic mobility shift assays (EMSA)
To assess the DNA binding activity of SRY in vitro, EMSA was
performed. Nuclear extracts were prepared from LNCaP cells
overexpressing SRY-3HA as described previously [36]. EMSA
was performed by using a LightShift EMSA optimization and
control kit (Pierce, Rockford, USA). The double-stranded
oligonucleotides correspond to the sequence 215 to +9( 5 9-
biotin-ATAGTTTGTTTCTTGGCTCCCTGT-39) of the
WDR5 promoter region. For the binding reaction, 20 fmol
biotin-labeled, double-stranded oligonucleotides were incubated
with nuclear extract (2–5 mg) in 16 binding buffer, 1 mg poly-
dI:dC, 20 min at room temperature. For competition studies,
unlabeled wild-type or mutant double-stranded oligonucleotides
(50-fold molar excess) were pre-incubated with nuclear extract
before addition of labeled oligonucleotides. For supershift assays,
extracts were preincubated with 2 mg mouse IgG or anti-HA
antibody for 15 min at room temperature before addition of the
probe. Reaction products were separated in 6.5% native
polyacrylamide gels in 0.56TBE buffer and visualized using the
LightShift EMSA kit (Pierce).
Chromatin Immunoprecipitation (ChIP) Assays
ChIP assays were performed as described previously [33,37].
For re-ChIP experiments, immunoprecipitates from the single
ChIP were eluted by incubation for 30 min, 37uCi n2 5ml1 0m M
dithiothreitol. The supernatant was removed, diluted at least
70 times using ChIP dilution buffer (1% Triton X-100, 2 mM
EDTA, 150 mM NaCl, 20 mM Tris-HCl [pH 8.1]) and then
subjected to another round of immunoprecipitation. PCR
amplification or realtime PCR was performed using the purified
DNA from either the single ChIP or the re-ChIP. For the in vivo
ChIP, carrier ChIP (cChIP) analysis was adopted form Bhandari
et al. [16]. Ten 13dpc rat gonads were used for the assay.
The ChIP primers for human WDR5 promoter were:
forward 59-CTGCTGCATTCTTACAGACTTCTGG,
reverse 59-TGACTACCATATTGAGCCCTGTAGC.
The ChIP primers for human WDR5 promoter proximal region
were:
forward 59-CCAGACCCACCAAGCCACTCAGT,
reverse 59-GGAACGTAACCGCTCAAAATGGCT
The ChIP primers for human Sox9 promoter were:
forward 59-ACCCTACCGTCCGCCCTTTG,
reverse 59-CCGCCTCACCTTAGAGCCAC.
The ChIP primers for human Sox9 promoter proximal region
were:
forward 59-CATCTATTCGATCAGTCAACAG,
reverse 59-CGCTGGGCTTGGAGAGTGTTTAT.
The ChIP primers for rat WDR5 promoter were:
forward 59-GTCAGCCAGGCAGTTGAGAGTAC,
reverse 59-AGCAGCCATCAGTCTCCCTCCAAT
The ChIP primers for rat Tcf21 promoter were:
forward 59-TCTCCACACTGGTGATTAACAAA,
reverse 59-TAATCCAGGCTCAGCTGAGA
Supporting Information
Figure S1 Diagram and alignment of WDR5 genes. (A)
Schematic representation of human WDR5 variants. Filled
rectangles indicate exons, empty rectangles indicate UTR. (B)
2000 bp upstream of the two WDR5 variants from different
vertebrates were aligned using the UCSC Genome Browser.
(TIF)
Figure S2 Co-immunoprecipitation and Western blot
analysis of MLL complex and SRY. WDR5 antibody
immunoprecipitates from vector-containing control (Ctrl) and
SRY-3HA-overexpressing (SRY-OE) cells were blotted with
indicated antibodies on the right.
(TIF)
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